Abstract
Recent advances in the field of pathology coupled with the rapid evolution of machine learning based techniques have revolutionized healthcare practices. Colorectal cancer accounts for one of the top 5 cancers with high incidence (126,240 in 2020) with a high mortality worldwide [1] [2]. Tissue biopsy remains to be the gold standard procedure for accurate diagnosis, treatment planning and prognosis prediction [3]. As an image based modality, pathology has attracted a lot of attention for development of AI algorithms and there has been a steady increase in the number of filings for FDA authorized use of AI algorithms in clinical practice [4]. The SemiCOL Challenge aims to develop computational pathology methods for automatic segmentation and classification of tumor and other tissue classes using H&E stained images. In this paper, we present a novel machine learning framework addressing the SemiCOL Challenge, focusing on semantic segmentation, segmentation-based whole-slide image classification, and effective use of limited annotated data. Our approach leverages deep learning techniques and incorporates data augmentation to improve the accuracy and efficiency of tumor tissue detection and classification in CRC. The proposed method achieves an average Dice score of 0.2785 for segmentation and an AUC score of 0.71 for classification across 20 whole-slide images. This framework has the potential to revolutionize the field of computational pathology, contributing to more efficient and accurate diagnostic tools for colorectal cancer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data was used from the SemiCOL competition as shared by the organizers. We were the Team Microscopy Mavericks and participated in this challenge and hence got access to the imaging data. https://www.semicol.org/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos